Get the Stockscreener App
22.92
3.21%
-0.76
After Hours:
23.49
0.57
+2.49%
Precipio Inc stock is traded at $22.92, with a volume of 187.18K.
It is down -3.21% in the last 24 hours and down -1.67% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$23.68
Open:
$23.76
24h Volume:
187.18K
Relative Volume:
3.41
Market Cap:
$40.97M
Revenue:
$25.83M
Net Income/Loss:
$-922.00K
P/E Ratio:
-44.43
EPS:
-0.5159
Net Cash Flow:
$555.00K
1W Performance:
-2.05%
1M Performance:
-1.67%
6M Performance:
-6.45%
1Y Performance:
+55.92%
1-Day Range:
$22.55
$24.10
1-Week Range:
$22.50
$24.75
52-Week Range:
$13.80
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
22.92 | 42.32M | 25.83M | -922.00K | 555.00K | -0.5159 |
TMO
Thermo Fisher Scientific Inc
|
559.53 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.20 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
137.89 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
258.03 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Precipio Inc Stock (PRPO) Latest News
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRPO|Precipio Inc|Price:23.490|Chg%:-0.190 - TradingKey
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio, Inc. Revenue Breakdown – NASDAQ:PRPO - TradingView
Precipio Announces Q1-2026 Shareholder Update Call - Moomoo
PRPO|Precipio Inc|Price:23.680|Chg%:+0.800 - TradingKey
Liquidity Mapping Around (PRPO) Price Events - Stock Traders Daily
Precipio Inc. (PRPO) Edges Higher as Shares Test Key Resistance LevelOvernight Profile - dars.gov.et
Form 4 Precipio Inc For: 16 July By Investing.com - Investing.com Nigeria
Precipio (PRPO) director receives 108-share stock grant for Q2-26 service - Stock Titan
Precipio, Inc. (PRPO) director gets 416-share stock grant for Q2 board fees - Stock Titan
Precipio, Inc. (PRPO) director takes stock in lieu of cash pay - Stock Titan
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy? - The Globe and Mail
Precipio Inc. (PRPO) Holds Steady at $24.0 as Consolidation PersistsSpring Pattern - dars.gov.et
Precipio Inc. Q2 2025 Earnings: Positive EPS of $0.05 Marks Notable Performance Despite Limited Revenue Disclosure - dars.gov.et
Why (PRPO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio - Yahoo Finance
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Growth Benchmark - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS of $0.05 Marks a MilestoneGuidance Revision Trend - dars.gov.et
Precipio Inc. (PRPO) Surges Past Key Resistance Level on Strong MomentumBull Pennant - dars.gov.et
Price to sales forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to EBITDA forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to revenue forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Precipio Is Requesting Shareholders/Brokers Vote Today to Avoid Costly Adjournment and Rescheduling of Annual Shareholders Meeting - Moomoo
Precipio, Inc. Actuals & Estimates (NASDAQ:PRPO) - TradingView
PRPO Q2 2025 Earnings: Positive Earnings per Share Signal TurnaroundBanking Earnings Report - DonanımHaber
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS of $0.05 Amidst Data Gaps; Stock DeclinesAnnual Earnings Summary - dars.gov.et
Understanding Momentum Shifts in (PRPO) - Stock Traders Daily
PRPO Q2 2025 Earnings: Positive EPS Achieved Amid Disclosed Revenue ReductionQuarterly Profit Report - DonanımHaber
Precipio Inc (PRPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precipio Inc (PRPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
PRPO: Rapid, profitable growth driven by innovative four-hour cancer diagnostics and scalable operations - TradingView
PRPO: Rapid, profitable growth driven by innovative diagnostics and strong customer retention - TradingView
Precipio Inc. (PRPO) Holds Near Support After Slight Decline, Key Levels in FocusPositive Gamma - dars.gov.et
Precipio (PRPO) AGM 2026 Summary - Quartr
Precipio Shareholders Back Board Nominees and Auditor - TipRanks
[8-K] Precipio, Inc. Reports Material Event - Stock Titan
Precipio to Present at the Planet MicroCap Las Vegas - The National Law Review
Precipio Inc Annual Shareholders Meeting Transcript - GuruFocus
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS Achieved Amid Stock DeclineEBITDA Analysis - newsline.com
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - The Manila Times
Precipio urges shareholders to vote ahead of Saturday meeting - Investing.com
Precipio urges shareholders to vote ahead of Saturday meeting By Investing.com - Investing.com Australia
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
2.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):